baber/WOPTO huggingface dataset:
Patent NL-9400591-A (NL)
Title: Aluminium reduction process involving the injection of carbon monoxide
Inventor: BRONKHORST RUDOLF NICO
IPC: C25C3/06
Filed: 1994-04-14
Abstract: The invention relates to the injection of carbon monoxide and carbon condensate into the electrolyte of the known "Hall-Heroult" process. This process achieves the electrolytic reduction of aluminium oxide to aluminium. Surprisingly it proved possible, in the production of carbon monoxide, as known under the name Boudouard equilibrium, for the equilibrium at which the maximum amount of carbon monoxide vis-à-vis carbon dioxide is formed to be likewise at the temperature of about 950 degree Celsius, which is about the same as the electrolyte temperature in the "Hall-Heroult" process. The carbon monoxide and carbon condensate is bubbled through the electrolyte where it then dissolves and electrolytically combines with the oxygen of the aluminium oxide in order then to form carbon dioxide and therefore aluminium.
Patent NL-9500292-A (NL)
Inventor: BINNEMA DOEDE JACOB
IPC: C12N9/90
Filed: 1995-02-16
Abstract: Conversion of a starch material utilizing a thermostable non-reducing glucan-forming enzyme activity (NRGFE), for instance from Sulfolobus solfataricus. Native starch is depolymerized at 60-120 DEG C and pH 4-9 in the presence of a thermostable NRGFE by means of thermostable glucanases, such as  alpha -amylases, isoamylases, pullulanases and/or amylopullulanases, with formation of Maillard products having been suppressed by virtue of the NRGFE activity present. The non-reducing glucans obtained can be used for the formation of trehalose by treating them with glucanases such as amylases, glucosidases and/or amyloglucosidases. Also, they can be modified with the aid of glucosyltransferases, for instance be treated with a thermostable phosphorylase in the presence of a glucosyl donor to raise the degree of polymerization, or be derivatized chemically or otherwise, optionally followed by a new hydrolytic treatment.
Patent PT-71942-A (PT)
Title: Coating compositions
IPC: C09D201/00
Filed: 1980-10-21
Abstract: A crosslinkable coating composition is described which is miscible in all proportions with water and consists of crosslinked water-insoluble polymer microparticles sterically stabilised in dispersion in a liquid blend of a water-soluble crosslinking agent and a water-soluble, non-volatile substance of molecular weight less than 1000 which can take part in the crosslinking reaction but does not dissolve or swell the polymer, the amounts of the crosslinking agent and of the water-soluble non-volatile substance being up to 30% and 40% respectively of the total weight of film-forming material.
Patent PT-73086-A (PT)
Title: Process for the preparation of a strictly sodium free dietetical salt
IPC: A23L27/23
Filed: 1981-05-26
Abstract: A stringently sodium-restricted dietetic salt consisting of a mixture of from 60 to 85% by weight of potassium chloride, from 10 to 30% by weight of potassium adipate, from 2 to 5% by weight of potassium tartrate, from 0.5 to 2% by weight of potassium glutamate, from 0.5 to 2% by weight of adipic acid and a total of from 0.004 to 0.06% by weight of potassium inosate and/or potassium guanylate, and the preparation of the salt in a fluidized bed apparatus.
Patent PT-76094-A (PT)
Title: Process for preparing <<2-<(nitropyridinyl) amino> phenyl>> arylmethanones useful for the manufacture of pyrido <1,4> benzodiazepines and of pharmaceutical compositions containing the same
Inventor: LO YOUNG SEK
IPC: C07D213/74
Filed: 1983-01-14
Abstract: [2-[(Nitropyridinyl)amino]phenyl]arylmethanones as chemical intermediates and/or having antidepressant activity having the formula:wherein;B is carbonyl, thioxomethyl, ketal orthioketal,R is hydrogen or-alk<sup>1</sup>-Q,Q is hydrogen, -NR<sup>1</sup>R<sup>2</sup> or halogenare disclosed in a process for preparing pyrido[1, 4]benzodiazepines.
Patent PT-77021-A (PT)
IPC: C07D495/04
Filed: 1983-07-12
Abstract: Novel benzothiopyranopyridinones of the formula    <IMAGE>  I wherein A,B,C and D are individually selected from the group consisting of hydrogen, alkyl and alkoxy of 1 to 6 carbon atoms, nitro, halogen, amino and acylamino of 2 to 7 carbon atoms or A and B or C and D taken with the carbon atoms to which they are attached form a benzene ring, R is selected from the group consisting of hydrogen and R', R' is selected from the group consisting of alkyl of 1 to 9 carbon atoms, alkenyl of 2 to 9 carbon atoms optionally substituted with an -OH, cycloalkyl of 3 to 9 carbon atoms, phenyl, aralkyl of 7 to 9 carbon atoms and -(CH2)n-Z, n is an integer from 1 to 4, Z is selected from the group consisting of cycloalkyl and cycloalkenyl of 3 to 9 carbon atoms, dioxanyl, 2-oxobenzimidazolyl, benzoyl, halo substituted benzoyl, cyano, alkoxy carbonyl of 2 to 7 carbon atoms and carbamoyl and their non-toxic, pharmaceutically acceptable acid addition salts having antipsychotic and antidepressant and antidopaminergic activity.
Patent PT-84966-A (PT)
Title: Non-corrosive security railing
Inventor: RUSSELL THOMAS R
IPC: E04H17/00
Filed: 1987-05-28
Abstract: A railing comprises sections each with an outer plastics pipe and a close-fitting inner pipe projecting from the outer pipe end, with posts and horizontal top rails each formed from one section. Top rail connectors each receive the projecting inner pipe ends and have o.d. equal to that of the outer pipes to form a smooth joint. The pipes are pref. of PVC, and there is a lower rail cross c connector body near the lower end of each post, cemented to the inner pipes and with the outer pipe in two sections abutting opposite sides of the connector. Horizontal lower rails formed form the sections are located between posts and cemented to the cross connectors.
Patent PT-88138-A (PT)
IPC: A61K9/70
Filed: 1988-07-28
Abstract: The invention relates to a process for producing an administration and/or dosage form for medicament active substances using a printing process, in which the printing process used is a pad printing process.
Patent PT-93416-A (PT)
Inventor: RIDLEY ROBERT GEORGE
IPC: G01N33/569
Filed: 1990-03-13
Abstract: The invention is concerned with antigenic polypeptides having a determinant or determinants immunologically cross-reactive with determinants on a polypeptide associated with the rhoptry organelles of the merozoite form of the malaria parasite Plasmodium falciparum. Further, the invention is concerned with immunogenic compositions which contain such a polypeptide and a suitable adjuvant, with DNAs coding for such a polypeptide, recombinant vectors containing such a DNA sequence, unicellular host organisms which contain such a replicable vector as well as antibodies which are directed against a polypeptide in accordance with the invention. Furthermore. the invention is concerned with a process for the production of the immunogenic compositions, of the microorganisms and of the antibodies as well as with the use of the polypeptides and the immunogenic compositions for the immunization of mammals against malaria.
Patent PT-94761-A (PT)
Inventor: FIBI MATHIAS
IPC: C07H21/04
Filed: 1990-07-19
Abstract: The invention relates to muteins of human erythropoietin (EPO) in the carboxy-terminal region which are prepared with the aid of DNA recombination techniques. These mutants have advantageous properties compared with human wild type EPO.
Patent PT-96078-A (PT)
Inventor: MENTION JACKY
IPC: A61K31/415
Filed: 1990-12-04
Abstract: Delayed-release oral dosage forms are described comprising cimetidine or a salt thereof and optionally a buffer that is capable of aiding dissolution of cimetidine in the intestine, coated with a release-delaying substance comprising a coating agent such as Eudragit<R> L 30 D.
Patent PT-96400-A (PT)
Inventor: AL-RAZZAK LAMAN A
IPC: A61P31/04
Filed: 1990-12-28
Abstract: Compositions of a quinolone carboxylic acids useful for oral or parenteral administration to a human or veterinary patient are disclosed which comprise quinolone carboxylic acid-metal ion-acid complexes in combination with a physiologically acceptable carrier and having a pH of about 4 to about 10, as well as a method for their production and use in treatment. Such compositions are found to cause unexpectedly low levels of vein irritation upon intravenous administration.
Patent SE-9000212-A (SE)
IPC: G05B19/042
Filed: 1990-01-22
Abstract: A system provides data communications between measurement data generating/receiving modules connected to a common communication bus. A master station connected to the communication bus can assign access priority to various message data structures generated by each of the modules connected to the communications bus. As modules are added or subtracted from the total system, the master station can reassign priorities to each of the message data structures generated by the modules. In this way, bus traffic can be efficiently controlled with the ability to dynamically change priority of message data structures which are sent over the bus by the various modules. A transmission delay time is also assigned to each of the message data structures which requires that a time out period following the last data message to be sent over the bus be observed before transmitting the new message data structure. The different delays VT are related to the particular priority of a message data structure.
Patent SI-9200383-A (SI)
Inventor: MERVA DRAGO
IPC: A47G23/04
Filed: 1992-12-14
Abstract: Izum se nanaša na posodo za hrambo začimb
in/ali živil, obsegajočo spodnji, hranilni del (1) in
zgornji, pokrovni del (2), ki v sestavljenem stanju
medsebojno tvorita oblikosklepno zvezo s sorazmerno
tesnim ujemom. Drug proti drugemu obrnjena
prosta konca hranilnega dela (1) in pokrovnega dela
(2) sta zasnovana z zastopničenjem, pri čemerje čelni
rob prostega konca hranilnega dela (1) na eni od
planparalelnih stranic (6,7), zasnovan s poglobitvijo
(9), tako da je pri prekritju s pokrovnim delom (2)
vsakokrat tvorjena špranja (10). Ena od planparalelnih
stranic pokrovnega dela (2) je na zastopničenem
odseku zasnovana z vsaj eno bradavico (11) ali
podobnim, ki pri zaprti posodi po izumu zagotavlja
stalen razmak na stičišču med zastopničenjem pokrovnega
dela (2) in zastopničenjem hranilnega dela
(1) in s tem stalno povezavo notranjosti posode po
izumu z okoliškim zrakom.
Patent RU-1732651-A (RU)
Title: 1-phenyl-3-(1,2,4-triazol-4-yl) urea salts having properties of plant growth regulators
Inventor: SHAPOVALOV A A
IPC: C07D249/08
Filed: 1990-03-11
Abstract: FIELD: agriculture. SUBSTANCE: present invention describes substituted urea, more particularly 1-phenyl-3-(1,2,4- triazol-4-yl) urea salts of general formula: $$$ wherein M is Na, K, $$$; n is 0 or 1 which are useful as plant growth regulators in agriculture. Synthesis is carried out by reacting 1-phenyl-3-(1,2,4-triazol-4-yl) urea alkalis or quaternary ammonium bases to attain substantially quantitative yield of desired substances, m.p., C, empirical formula: (a) 279-280, $$$; (b) 213 (decomposition), $$$; (c) 139-141, $$$; (d) 154, $$$; (e) 88-90, $$$ (f) 159-160, $$$. Novel compounds have high cytokininic activity and low toxicity ($$$-1200-1500 mg/kg). EFFECT: more active agents of this class. 6 tbl
Patent UA-15554-A (UA)
Filed: 1989-08-14
Abstract: Способ прогнозирования эффективности рефлексотерапии включает проведение исследований состояния организма. Определяются показатели фагоцитоза в мазке и в литре крови до начала лечения, до и после 3-4 сеансов и при снижении показателей более чем на 35% прогнозируется эффективность лечения.
Patent UA-13166-A (UA)
Title: Flow control regulator
Filed: 1991-03-19
Abstract: The regulator comprises the body with delivery and waste channels and an axial counterbore where a new cylinder is mounted and made with input and output radial windows connected correspondingly with delivery and waste channels in the body placed in the quill cylinder with opportunity of axial transference, the sleeve with the first pair of radial apertures forming output throttling links with output quill cylinder windows and a closed axial hole, a spring mounted with opportunity of interaction with the sleeve and a rotating driver where the cavities formed by inner surface of the body and end face surface of the sleeve are connected correspondingly with delivery channels and the cavity formed in the sleeve by its axial aperture.
Patent BG-100939-A (BG)
Title: -1-antichymotrypsin analogues having elastase inhibitory activity
Inventor: COOPERMAN BARRY S
IPC: A61P31/04
Filed: 1996-10-28
Abstract: The present invention provides an analogue of human alpha-1-antichymotrypsin where the amino acid at position 358 is selected from the group consisting of methionine, isoleucine, valine, alanine, aspartic acid, threonine, and glutamic acid. The alpha-1-antichymotropsin analogues of the present invention are efficient inhibitors of human neutrophil elastase. The present invention also provides nucleic acide sequences encoding said analogues, expression vectors, transformed host cells, and a method of producing the analogues.
Patent BG-101446-A (BG)
Title: Antineoplastic cocoa extracts, methods for making, using
Inventor: ROMANCZYK JUN LEO J
IPC: A61K36/00
Filed: 1997-04-25
Abstract: Disclosed and claimed are cocoa extracts such as polyphenolsor procyanidins, methods for preparing such extracts, as well asusers for them, especially as antineoplastic agents andantioxidants. Disclosed and claimed are antineoplasticcompositions containing cocoa polyphenols or procyanidins andmethods for treating patients employing the compositions.Additionally disclosed and claimed is a kit for treating a patientin need of treatment with an antineoplastic agent containing cocoapolyphenols or procyanidins as well as a lyophilizedantineoplastic composition containing cocoa polyphenols orprocyanidins. Further, disclosed and claimed is the use of theinvention in antioxidant, preservative andtopiosomerase-inhibiting compositions and methods.26 claims
Patent BG-102028-A (BG)
Title: Transaction recovery in a value transfer system
Inventor: EVERETT DAVID BARRINGTON
IPC: G06Q20/34
Filed: 1997-11-06
Abstract: A value transfer system for transferring value intransactions between electronic purses as electronic cash has atransaction failure recovery procedure whereby a pending logstores transaction messages after they are sent. On detection ofan error an interface device (IFD) can issue a payment resumecommand to re-send the last transaction message and resume thetransaction.8 claims, 10 figures
Patent BG-105007-A (BG)
Title: Pre-processing and post-processing for enhancing knowledge discovery using support vector machines
Inventor: BARNHILL STEPHAN D
IPC: G06N20/10
Filed: 2000-11-30
Abstract: A system and method for enhancing knowledge discovery from data using a learning machine in general and a support vector machine in particular. Training data for a learning machine is pre-processed in order to add meaning thereto. Pre-processing data may involve transforming the data points and/or expanding the data points. By adding meaning to the data, the learning machine is provided with a greater amount of information for processing. With regard to support vector machines in particular, the greater the amount of information that is processed, the better generalizations about the data that may be derived. The learning machine is therefore trained with the pre-processed training data and is tested with test data that is pre-processed in the same manner. The test output from the learning machine is post-processed in order to determine if the knowledge discovered from the test data is desirable. Post processing involves the interpreting the test output into a format that may be compared with the test data. Live data is pre-processed and input into the trained and tested learning machines. The live output from the learning machine may then be post-processed into a computationally derived alphanumerical classifier for interpretation by a human or computer automated process. 108 claims, 12 figures
Patent BG-105919-A (BG)
Title: Erythromycin derivatives
Inventor: KATO HIDEO
IPC: A61P31/04
Filed: 2001-09-19
Abstract: The derivatives of erythromycin and their salts can be used as antimicrobial agents. They have the general formula wherein R is H or lower alkyl; R1 is alkyl, cycloalkyl, (cycloalkyl)alkyl, aralkyl, or -(CH2)n-X-R4; R2 is H or acetyl; R3 is acyl or -C(=O)-Y-R5; R4 is alkyl, alkoxyalkyl, alkylthioalkyl, alkylaminoalkyl, aryl, or aralkyl; R5 is alkyl, aryl or aralkyl; n is an integer of 1 to 6; X is O, S or -NZ; Y is O or -NH-; and Z is H or alkyl. 8 claims
Patent BG-106291-A (BG)
Title: Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
Inventor: AUGELLI-SZAFRAN CORINNE E
IPC: C07D401/12
Filed: 2002-01-09
Abstract: The present invention provides a method treating Alzheimer's disease using a novel compound of formula wherein X is phenyl or substituted phenyl; Y is phenyl, substituted phenyl, pyridyl, or substituted pyridyl. Also provided is a method of inhibiting the aggregation of amyloid proteins using a compound of said formula, and a method of imaging amyloid deposits using isoindoline derivatives. 19 claims
Patent BG-107105-A (BG)
Title: Method for improving the filling ability of tobacco
Inventor: BURMESTER ULRICH
IPC: A24B3/18
Filed: 2002-09-13
Abstract: The invention relates to a method for improving the filling ability of tobacco, such as cut tobacco leaves, or ribs, of tobacco additives, whereby the tobacco material with an initial water content of up to 15 wt.% is treated with a gas, comprising nitrogen and/or argon, at pressure from 50 to 1000 bar with a continuous, or staged compression, followed by a continuous or staged decompression, whereby the compression and decompression steps occur in, either an autoclave, or a cascade-like series of several autoclaves and, finally, a thermal after-treatment of the withdrawn tobacco material. The invention is characterized in that the compression is carried out at a working temperature of over 55 degrees C, preferably from 60 to 90 degrees C and the final water content of the tobacco is in the range of 8 to 14 wt.%. 3 claims
Patent BG-107649-A (BG)
Title: Effervescent medicamentous form
Inventor: NAJDENOV VLADIMIR J
IPC: A61K9/46
Filed: 2003-03-20
Abstract: The effervescent medicamentous form, in particular effervescent candy tablets provoke the saliva separation and ensure continuous, full contact of the active effect substances in the oral cavity mucous membrane and the upper respiratory tracts. The effervescent tablets contain, in wt.%, active substance of natural origin of 0.0010-0.500 and if required, vitamins 0.0001-0.400 and/or minerals 0.00001-0.400; pharmaceutically acceptable organic acid 0.090-0.300; alkaline carbonate and/or alkaline hydrogen carbonate, and/or alkaline glycine carbonate 0.100-0.300; glucidex as binder 0.100-0.500; mannitol as solvent 0.100-0.350 and/or lactose 0.050-0.450; and auxiliary substances 0.020-1.500. The active substance can be vegetative extract of Matricria Chamomilla, Echinaceae rosea, Valeriana officinalis, Salvia officinalis, Aloe Vera, Tilia grandifolia, Hypericum perforatum, Thimus serpyllum, Calendula officinalis, Plantago lanceolata. Achilea millefolium, Origanum vulgare, Rodiola rosea, Livsea, Artemisia absinthinium, Cartaegus monogyna, as well as a mixture of essential oils or bee product. 4 claims
Patent BG-111942-A (BG)
Title: Изделие за адаптиране на мобилен телефон
Inventor: SAVOV PLAMEN
IPC: H04B1/38
Filed: 2015-02-26
Abstract: Изобретението се отнася до изделие за адаптиране на мобилен телефон към ръката на потребител. Предимство на изделието е осигуряване на бързо и лесно ползване на мобилния телефон, без риск от нарушаване ~a целостта или повреждане на устройството, елиминира страничните шумовете по време на разговор. спасява от пропускане на разговор. дава възможност за използване основно на вибрационния сигнал на мобилното устройство, приложимо е при всички стандартни видове мобилни устройство и елиминира труда за изваждане и връщане на мобилния телефон от и на мястото за съхранение. Изделието се състои от три свързани неразривно помежду си компонента: калъф за мобилен телефон (1) с USB конектор (4) и допълнителен микрофон (3), закрепен към ръката на потребителя с каишка (6) и израстък-щипка (8) на края на която са изведени бутон за включване/ изключване на мобилния телефон (11). камера (12) и слушалка (10).
Patent BG-112015-A (BG)
Title: Method and equipment for rotary pyrolisis
Inventor: KASABOV EVGENI
IPC: B01J19/18
Filed: 2015-05-18
Abstract: The current invention relates to a method and equipment for rotary pyrolysis, a usage for which is found in burning off waste biomass. With the rotary pyrolysis method, the needed heat is created by burning hydrogen created outside, through water electrolysis. High temperatures are generated without creating nitrogen oxides. In this method pyrolysis is achieved in both a stationary and moving rotary and vibrating pseudo-boiling layer. The mechanism includes a vertically positioned rotary pyrolysis reactor, enabled with a tangentially positioned power device, a mechanism placed in the lower part of the reactor for removing hard solids and a recirculation contour positioned on the side of the corpus (1) of the reactor. The corpus (1) is comprised of a cone- shaped base (2) and a cylindrical part (3), as the power device is placed in the middle of that cylinder part (3). On the two sides of the power device, are made, vertically, one underneath the other, top to bottom holes, in which are placed an upper (16) and a lower (17) steam nozzle, under which in openings in the cone-shaped base (2) are mounted hydrogen torches (18). Between the hydrogen torches (18) and the lower steam nozzles (17) are mounted steam ejectors (20).
Patent CN-1352090-A (CN)
Title: 一种新的多肽——人剪接因子蛋白10.45和编码这种多肽的多核苷酸
Inventor: MAO YUMIN
IPC: C12N15/113
Filed: 2000-11-06
Abstract: 本发明公开了一种新的多肽——人剪接因子蛋白10.45,编码此多肽的多核苷酸和经DNA重组技术产生这种多肽的方法。本发明还公开了此多肽用于治疗多种疾病的方法,如恶性肿瘤,血液病,发育紊乱症,HIV感染,免疫性疾病和各类炎症等。本发明还公开了抗此多肽的拮抗剂及其治疗作用。本发明还公开了编码这种新的人剪接因子蛋白10.45的多核苷酸的用途。
Patent CN-1358104-A (CN)
Title: 低剂量雌激素间断激素补偿治疗
Inventor: CASPER R F
IPC: A61P5/30
Filed: 2000-03-22
Abstract: 一种激素补偿治疗,含有多个每日剂量的药物制剂,所述剂量用于在三个每日剂量的交替阶段连续和持续给药,雌激素活性相对主导阶段含有三个每日剂量的显示相当于1mg/天17β－雌二醇/天的雌激素活性物质,孕激素活性相对主导阶段为一种组合物,所述组合物的组成是:显示相当于约1mg/天17β－雌二醇的雌激素活性物质物质和显示相当于约90μg/天诺孕酯的孕激素活性物质。
Patent CN-1404294-A (CN)
Title: 固定电话网的信息提供方法
Inventor: ZHANG JIPING
IPC: H04M3/42
Filed: 2001-09-06
Abstract: 一种固定电话网的信息提供方法，用于为固定电话网的信息终端提供信息服务，其中一个信息提供系统接收一个信息终端的服务请求，为其提供综合信息服务。通过该信息提供方法，为信息终端提供包括短消息收发，信息订阅，信息点播等的多种信息服务。
Patent CN-1337622-A (CN)
Title: 在实时多任务操作系统中建立嵌入式图形化用户界面的方法
Inventor: WU DI
IPC: G06F9/445
Filed: 2001-09-25
Abstract: 本发明公开了一种在微内核实时多任务操作系统中建立嵌入式图形化用户界面的方法,该方法包括步骤:对图形化用户界面(CUI)进行初始化,CUI启动必要的系统定时器,读入变电站各个保护间隔的配置文件并存储在其内存区;系统登录并判断是否是合法用户,如果登录失败,允许用户重新登录,或直接退出系统,并释放动态分配的内存;如果系统登录成功,建立主用户界面窗口并对用户开放事件输入的接口,通过接口输入事件消息;根据输入事件消息,输出有关事件。根据本发明方法建立的CUI的功能简洁,操作简单,界面直观,可以提供用户方便地查询变电站全面的信息,并可以协助用户对变电站的设备进行必要的操作。
Patent CN-1417394-A (CN)
Title: 聚酯不同收缩混合纱的制造方法及其装置
Inventor: BO-HAN GR
IPC: D01H1/14
Filed: 2002-01-15
Abstract: 本发明提供聚酯不同收缩混合纱的制造方法及装置，其特征在于通过纺纱锤将纺纱的聚酯pillament熔融，根据需要不同温度的织物的染色性，通过分别具有温度调节装置的不同温度的热管，并利用可调节适当张力的两个滚轴之间和卷取器上部的空气交错装置进行合纱，制造不同收缩混合纱。因此，本发明的制造工艺和装置简单，节约设备费和人力费，大大提高生产能力，非常有用。
Patent CN-1458756-A (CN)
Title: 宽带码分多址多径分集接收机的数据缓存方法和装置
Inventor: CHEN YUEFENG
IPC: H04J13/00
Filed: 2002-05-17
Abstract: 本发明所述宽带码分多址多径分集接收机的数据缓存方法，采用存储器组对输入数据进行存储，由计数器产生写地址和写控制信号，根据由多径相位和写地址产生的存储器读地址读取数据，并经过重新排列后输出数据进行解调，消除了不同多径相位偏移的解调的时间差，达到了消除多径相位的时间差、降低系统后续处理复杂程度的效果。
Patent CN-1471071-A (CN)
Inventor: CHEN YANHUA
IPC: G09G3/3208
Filed: 2002-07-24
Abstract: 本发明涉及一种使有机发光二极体显示器呈现多种灰阶的方法，该方法主要是使用一种电源供应电路连接于显示器内的每一条资料线，藉由控制电源供应电路中的每一个开关，以供应一合成电流至相连接的资料线，而驱动该每一个有机发光二极体，此时有机发光二极体会因不同大小的电流值而呈现多种灰阶的效果。
Patent CN-1419288-A (CN)
Title: 改善玻璃钝化硅器件高温反向特性的钝化玻璃涂敷液
Inventor: LIN LIQIANG
IPC: H01L21/00
Filed: 2002-12-19
Abstract: 本发明提供一种通过玻璃涂敷液中添加剂的作用，尽可能地消除游离的可动离子的沾污影响并抑制玻璃钝化器件在高温反偏作用下可动离子的电徙动，从而达到进一步提高玻璃钝化器件反向特性，提高器件可靠性的目的。添加剂可采用H 2 O 2 或HCl，也可采用了H 2 O 2 加HCl复合型试剂，本发明其特征是在钝化玻璃涂敷液中按玻璃粉含量每100克重量加入(0.5－7.5)×10 －3 克分子H 2 O 2 或(0.5－7)×10 －3 克分子HCl。